• No results found

Hyperhomocysteinemia and venous thrombosis : studies into risk and therapy

N/A
N/A
Protected

Academic year: 2021

Share "Hyperhomocysteinemia and venous thrombosis : studies into risk and therapy"

Copied!
7
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

therapy

Willems, H.P.J.

Citation

Willems, H. P. J. (2006, November 29). Hyperhomocysteinemia and venous thrombosis :

studies into risk and therapy. Retrieved from https://hdl.handle.net/1887/5417

Version:

Corrected Publisher’s Version

License:

Licence agreement concerning inclusion of doctoral thesis in the

Institutional Repository of the University of Leiden

Downloaded from:

https://hdl.handle.net/1887/5417

(2)

Hyperhomocysteinemia and venous thrombosis

Studies into risk and therapy

(3)
(4)

Hyperhomocysteinemia and venous thrombosis

Studies into risk and therapy

PROEFSCHRIFT

ter verkrijging van

de graad van Doctor aan de Universiteit Leiden, op gezag van de rector Magnificus Dr. D.D. Breimer,

hoogleraar in de faculteit der Wiskunde en Natuurwetenschappen en die der Geneeskunde,

volgens besluit van het College voor Promoties te verdedigen op

woensdag 29 november 2006 klokke 16.15 uur

door

(5)

Promotor Prof. dr. F.R. Rosendaal Co-promotores Dr. G.M.J. Bos Dr. M. den Heijer Referent Prof. dr. H.R. Büller Overige leden Prof. dr. A. Algra Dr. H. Blom

Prof. dr. A.J. Rabelink

(6)

Contents

Chapter 1 General introduction 7 Chapter 2 Homocysteine and venous thrombosis: outline of a vitamin 15 intervention trial

Chapter 3 Acidic citrate stabilizes blood samples for assay of 31 total homocysteine.

Chapter 4 Comparison between acidic citrate and EDTA as anticoagulant 39 for measurement of homocysteine concentration

Chapter 5 Influence of coumarins on homocysteine concentration. 51 Chapter 6 The elevated risk for venous thrombosis in persons 63

with hyperhomocysteinemia is not reflected by the endogenous thrombin potential

Chapter 7 Homocysteine as risk factor for venous thrombosis in the 69 elderly

Chapter 8 Homocysteine lowering by B vitamins and the prevention 77 of deep-vein thrombosis and pulmonary embolism.

A randomized, placebo-controlled, double-blind, secondary prevention intervention trial.

Chapter 9 General discussion 91

Samenvatting 99

Dankwoord 103

(7)

Referenties

GERELATEERDE DOCUMENTEN

We found a difference of 1.3 μmol/l (95% CI 0.9 to 1.6 μmol/l) between tHcy concentrations measured in blood sampled in tubes with EDTA and stored at 0°C and tHcy

Reference values need to be established when using acidic citrate tubes since individual values differ from those measured in EDTA samples and the difference is dependent on the

Although the possible effect of anticoagulans on homocysteine values is very low, we analyzed if the 1 μmol/l increase in homocysteine concentration found in the surgery group

In order to see whether a plasmatic component can explain the thrombotic tendency in HH, we tested the possible relationship between the concentration of homocysteine (tHcy)

We therefore performed a case-control study among elderly patients to evaluate whether elevated homocysteine levels are a risk factor for venous thrombosis in this age

Sample size was calculated for the hyperhomocysteinemic group: With alpha=0.05 and beta=0.2 and with an expected recurrence rate of 20% in patients with idiopathic thrombosis

After the relationship of elevated homocysteine concentrations and venous thrombosis was established by our research group and others in earlier studies a main issue is

Het bleek dat in de groep met hoge homocysteïne waarden bij het begin van het onderzoek, vitamine B het homocysteïne weliswaar deed dalen maar het risico op trombose niet